Clinical Signficance of p53, Proliferating Cell Nuclear Antigen and bcl-2 Expression in Bladder Transitional Cell Carcinoma

By Zhu Zhaohui   Cheng Ping   Zeng Fuqing   Lu Gongcheng   Xing Shian  

The Chinese-German Journal of Clinical Oncology, Vol. 3, Iss. 1, 2004-03 ,pp. : 20-23

Springer Publishing Company

Access to resources Recommend Favorite

Transitional cell carcinoma of the urinary bladder metastatic to the oral mucosa

By Lee Kyu Seob   Song Ik Chan   Yun Hwan Jung   Jo Deog Yeon   Kim Samyong   Lee Hyo Jin  

Oncology Letters, Vol. 3, Iss. 2, 2012-02 ,pp. : 343-345

Spandidos Publications

Access to resources Recommend Favorite

Semi-quantitative analysis of telomerase activity of exfoliated cells in urine of patients with urothelial cancers: - A potential marker of bladder transitional cell carcinoma in bladder washes

By Akao T.   Kakehi Y.   Wu X.-X.   Kinoshita H.   Takahashi T.   Ogawa O.   Kato T.   Yoshida O.  

Urologic Oncology: Seminars and Original Investigations, Vol. 3, Iss. 4, 1997-07 ,pp. : 118-124

Elsevier

Access to resources Recommend Favorite

Diagnostic value of fibronectin and mutant p53 in the urine of patients with bladder cancer: impact on clinicopathological features and disease recurrence

By Eissa Sanaa  

Medical Oncology, Vol. 27, Iss. 4, 2010-12 ,pp. : 1286-1294

Humana Press, Inc

Access to resources Recommend Favorite

p53 Immunoreactivity in biopsy specimens of T1G3 transitional cell carcinoma of the bladder- a helpful parameter in guiding the decision for or against cystectomy?

By Steiner G.   Bierhoff E.   Schmidt D.   Leissner J.   Wolf H.K.   Albers P.  

European Journal of Cancer, Vol. 36, Iss. 5, 2000-03 ,pp. : 610-614

Elsevier

Access to resources Recommend Favorite